Literature DB >> 19641506

Bim and Bmf in tissue homeostasis and malignant disease.

J D Piñon1, V Labi, A Egle, A Villunger.   

Abstract

Among all BH3-only proteins known to date, most information is available on the biological role and function of Bim (Bcl-2 interacting mediator of cell death)/BOD (Bcl-2 related ovarian death agonist), whereas little is still known about its closest relative, Bcl-2 modifying factor (Bmf). Although Bim has been implicated in the regulation of cell death induction in multiple cell types and tissues in response to a large number of stimuli, including growth factor or cytokine deprivation, calcium flux, ligation of antigen receptors on T and B cells, glucocorticoid or loss of adhesion, Bmf seems to play a more restricted role by supporting Bim in some of these cell death processes. This review aims to highlight similarities between Bim and Bmf function in apoptosis signaling and their role in normal development and disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19641506      PMCID: PMC3272400          DOI: 10.1038/onc.2009.42

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  96 in total

1.  Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity.

Authors:  P Bouillet; D Metcalf; D C Huang; D M Tarlinton; T W Kay; F Köntgen; J M Adams; A Strasser
Journal:  Science       Date:  1999-11-26       Impact factor: 47.728

2.  Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis.

Authors:  H Puthalakath; A Villunger; L A O'Reilly; J G Beaumont; L Coultas; R E Cheney; D C Huang; A Strasser
Journal:  Science       Date:  2001-09-07       Impact factor: 47.728

3.  The proapoptotic BH3-only protein bim is expressed in hematopoietic, epithelial, neuronal, and germ cells.

Authors:  L A O'Reilly; L Cullen; J Visvader; G J Lindeman; C Print; M L Bath; D C Huang; A Strasser
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

4.  Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis.

Authors:  C M Eischen; D Woo; M F Roussel; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

5.  Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1.

Authors:  P F Dijkers; R H Medema; J W Lammers; L Koenderman; P J Coffer
Journal:  Curr Biol       Date:  2000-10-05       Impact factor: 10.834

6.  Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim.

Authors:  P Bouillet; S Cory; L C Zhang; A Strasser; J M Adams
Journal:  Dev Cell       Date:  2001-11       Impact factor: 12.270

7.  A novel Bim-BH3-derived Bcl-XL inhibitor: biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activity.

Authors:  Raffaella Ponassi; Barbara Biasotti; Valeria Tomati; Silvia Bruno; Alessandro Poggi; Davide Malacarne; Guido Cimoli; Annalisa Salis; Sarah Pozzi; Maurizio Miglino; Gianluca Damonte; Pietro Cozzini; Francesca Spyrakis; Francesca Spyraki; Barbara Campanini; Luca Bagnasco; Nicoletta Castagnino; Lorenzo Tortolina; Anna Mumot; Francesco Frassoni; Antonio Daga; Michele Cilli; Federica Piccardi; Ilaria Monfardini; Miriam Perugini; Gabriele Zoppoli; Cristina D'Arrigo; Raffaele Pesenti; Silvio Parodi
Journal:  Cell Cycle       Date:  2008-10-20       Impact factor: 4.534

8.  Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic.

Authors:  Mark S Cragg; Elisa S Jansen; Michele Cook; Claire Harris; Andreas Strasser; Clare L Scott
Journal:  J Clin Invest       Date:  2008-10-23       Impact factor: 14.808

9.  The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia.

Authors:  C Ploner; J Rainer; H Niederegger; M Eduardoff; A Villunger; S Geley; R Kofler
Journal:  Leukemia       Date:  2007-11-29       Impact factor: 11.528

10.  BAX activation is initiated at a novel interaction site.

Authors:  Evripidis Gavathiotis; Motoshi Suzuki; Marguerite L Davis; Kenneth Pitter; Gregory H Bird; Samuel G Katz; Ho-Chou Tu; Hyungjin Kim; Emily H-Y Cheng; Nico Tjandra; Loren D Walensky
Journal:  Nature       Date:  2008-10-23       Impact factor: 49.962

View more
  56 in total

1.  Bcl-2 phosphorylation confers resistance on chronic lymphocytic leukaemia cells to the BH3 mimetics ABT-737, ABT-263 and ABT-199 by impeding direct binding.

Authors:  Ting Song; Gaobo Chai; Yubo Liu; Xiaoyan Yu; Ziqian Wang; Zhichao Zhang
Journal:  Br J Pharmacol       Date:  2016-01-16       Impact factor: 8.739

2.  Grb10 interacts with Bim L and inhibits apoptosis.

Authors:  Zhi-qian Hu; Jia-yi Zhang; Chao-neng Ji; Yi Xie; Jin-zhong Chen; Yu-min Mao
Journal:  Mol Biol Rep       Date:  2010-02-20       Impact factor: 2.316

3.  Pro-apoptotic Bim suppresses breast tumor cell metastasis and is a target gene of SNAI2.

Authors:  D Merino; S A Best; M-L Asselin-Labat; F Vaillant; B Pal; R A Dickins; R L Anderson; A Strasser; P Bouillet; G J Lindeman; J E Visvader
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

4.  BCL-2 modifying factor (BMF) is a central regulator of anoikis in human intestinal epithelial cells.

Authors:  Martin Hausmann; Katharina Leucht; Christian Ploner; Stephan Kiessling; Andreas Villunger; Helen Becker; Claudia Hofmann; Werner Falk; Michaela Krebs; Silvia Kellermeier; Michael Fried; Jürgen Schölmerich; Florian Obermeier; Gerhard Rogler
Journal:  J Biol Chem       Date:  2011-06-14       Impact factor: 5.157

5.  The epigenetic regulator I-BET151 induces BIM-dependent apoptosis and cell cycle arrest of human melanoma cells.

Authors:  Stuart J Gallagher; Branka Mijatov; Dilini Gunatilake; Jessamy C Tiffen; Kavitha Gowrishankar; Lei Jin; Gulietta M Pupo; Carleen Cullinane; Rab K Prinjha; Nicholas Smithers; Grant A McArthur; Helen Rizos; Peter Hersey
Journal:  J Invest Dermatol       Date:  2014-06-06       Impact factor: 8.551

6.  JNK Promotes Epithelial Cell Anoikis by Transcriptional and Post-translational Regulation of BH3-Only Proteins.

Authors:  Nomeda Girnius; Roger J Davis
Journal:  Cell Rep       Date:  2017-11-14       Impact factor: 9.423

7.  Restraining FOXO3-dependent transcriptional BMF activation underpins tumour growth and metastasis of E-cadherin-negative breast cancer.

Authors:  M Hornsveld; M Tenhagen; R A van de Ven; A M M Smits; M H van Triest; M van Amersfoort; D E A Kloet; T B Dansen; B M Burgering; P W B Derksen
Journal:  Cell Death Differ       Date:  2016-04-01       Impact factor: 15.828

8.  The oncogenic tyrosine kinase Lyn impairs the pro-apoptotic function of Bim.

Authors:  Lazaro E Aira; Elodie Villa; Pascal Colosetti; Parvati Gamas; Laurie Signetti; Sandrine Obba; Emma Proics; Fabien Gautier; Béatrice Bailly-Maitre; Arnaud Jacquel; Guillaume Robert; Frédéric Luciano; Philippe P Juin; Jean-Ehrland Ricci; Patrick Auberger; Sandrine Marchetti
Journal:  Oncogene       Date:  2018-02-02       Impact factor: 9.867

9.  Loss of H2B monoubiquitination is associated with poor-differentiation and enhanced malignancy of lung adenocarcinoma.

Authors:  Keqiang Zhang; Jinhui Wang; Tommy R Tong; Xiwei Wu; Rebecca Nelson; Yate-Ching Yuan; Theresa Reno; Zheng Liu; Xinwei Yun; Jae Y Kim; Ravi Salgia; Dan J Raz
Journal:  Int J Cancer       Date:  2017-05-31       Impact factor: 7.396

10.  BH3-only protein Bmf mediates apoptosis upon inhibition of CAP-dependent protein synthesis.

Authors:  F Grespi; C Soratroi; G Krumschnabel; B Sohm; C Ploner; S Geley; L Hengst; G Häcker; A Villunger
Journal:  Cell Death Differ       Date:  2010-08-13       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.